PROVETOP

Biotinylated Human CEACAM-6/CD66c Protein

Catalog No: CEACAM6-HB003

Species
Human
Expression System
HEK293
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Human CEACAM-6/CD66c Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Lys35-Gly320 (UniProt accession: P40199).

Product Details

Molecular Aliases
CEACAM6; CD66c; CEAL; NCA; CEA
Protein Length
Lys35-Gly320
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 34.1 kDa. Due to glycosylation, the protein migrates to 55-75 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
CEACAM6-HB003 Bis-Tris-PAGE-white result

Biotinylated Human CEACAM-6 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
CEACAM6-HB003 SEC-HPLC result

The purity of Biotinylated Human CEACAM-6 is greater than 95% as determined by SEC-HPLC.

SPR
CEACAM6-HB003 SPR result

Human CEACAM-8, His Tag immobilized on CM5 Chip can bind Biotinylated Human CEACAM6, His-Avi tag with an affinity constant of 3.81 μM as determined in SPR assay (Biacore T200).

Background

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) belongs to the human carcino-embryonic antigen (CEA) family. Numerous lines of studies have indicated that altered expression of CEACAM6 may have a role in carcinogenesis and development.

References

  1. Sharma N, Srivastava S, Kern F, et al. CEACAM 6, a novel marker for the diagnosis of Barrett's esophagus. Dis Esophagus. 2017;30(7):1-5. doi:10.1093/dote/dox026

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support